D-0506-2026 Class II Ongoing
FDA drug recall D-0506-2026 was initiated by Wells Pharma of Houston LLC on April 1, 2026 and is designated Class II. Reason for recall: cGMP deviations. The recall status is ongoing. Affected quantity: 150 syringes.
Recall Details
- Product Type
- Drugs
- Report Date
- May 6, 2026
- Initiation Date
- April 1, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 150 syringes
Product Description
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65.
Reason for Recall
cGMP deviations.
Distribution Pattern
U.S. Nationwide.
Code Information
Lot 022326203650432; Exp Date 06/25/2026